Related Experiment Video
Updated: Feb 10, 2026

Embolic Middle Cerebral Artery Occlusion MCAO for Ischemic Stroke with Homologous Blood Clots in Rats
Published on: September 17, 2014
Management of Embolic Stroke of Undetermined Source (ESUS)
Tobias Geisler1, Annerose Mengel2, Ulf Ziemann2
1Department of Cardiology, University Hospital Tübingen, Otfried-Müller-Straße 10, 72076, Tübingen, Germany. tobias.geisler@med.uni-tuebingen.de.
Abstract:
According to the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) classification, embolic stroke of undetermined source (ESUS) has refined the old definition of cryptogenic stroke. More sophisticated criteria and a well-defined diagnostic workup point out the embolic nature of this disease. Because ESUS is associated with a high stroke recurrence, a clear risk prediction and management is of utmost importance to improve prognosis. To date, standard pharmacotherapy consists of antiplatelet drugs and statins. This review attempts to provide an overview on the diagnostic criteria, prognosis, and current clinical trials evaluating the value of direct oral anticoagulants for secondary prevention after ESUS.
Related Concept Videos
Pulmonary Embolism III: Nursing Management
Pulmonary Embolism I: Introduction
Sinusoidal Sources
In homes, the power supplies use sinusoidal sources to provide electricity. These sources generate a voltage that varies sinusoidally...
AC Sources
Sources of Law
Constitutional law is foundational, deriving from federal and state constitutions, and...
Source Transformation
It is essential to note that when...

